UK authorises Pfizer-BioNTech COVID-19 vaccine
The Government has accepted a recommendation from the MHRA to approve Pfizer-BioNTech’s COVID-19 vaccine for use. The MHRA were satisfied that the vaccine has met its strict standards of safety, quality and effectiveness.
Source:
Department of Health and Social Care
SPS commentary:
The Joint Committee on Vaccination and Immunisation (JCVI) have finalised their recommendations on priority groups for vaccination today, which will be updated following consideration of Phase III safety and efficacy data on other COVID-19 vaccines.
All evidence indicates that the best option for preventing morbidity and mortality in the initial phase of the programme is to directly protect persons most at risk of morbidity and mortality. The highest priority population are residents in a care home for older adults and their carers, followed by all those 80 years of age and over, and frontline health and social care workers.